Norway Cell Separation Market Size & Outlook, 2023-2030
Norway cell separation market, 2018-2030 (US$M)
Related Markets
Norway cell separation market highlights
- The Norway cell separation market generated a revenue of USD 56.2 million in 2023 and is expected to reach USD 86.8 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell separation market data book summary
| Market revenue in 2023 | USD 56.2 million |
| Market revenue in 2030 | USD 86.8 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
Other key industry trends
- In terms of revenue, Norway accounted for 0.6% of the global cell separation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK cell separation market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,002.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Separation Market Scope
Cell Separation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway cell separation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.48% in 2023. Horizon Databook has segmented the Norway cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Norway has an advanced biotechnology industry, a favorable investment climate, supportive policies, and incentives for biotechnology & biopharmaceutical companies. In addition, Norway’s well-developed infrastructure, including advanced laboratories, manufacturing facilities, and quality control systems, supports the life sciences industry.
Furthermore, the presence of established scientific institutions involved in cell separation activities is expected to support market growth over the forecast period. For instance, Oslo University Hospital has a Flow Cytometry Core Facility that offers flow cytometry analysis and cell sorting services since 1995.
In Norway, the EU MDR and IVDR were implemented through the Act on Medical Devices in May 2021. The country is a member of the European Free Trade Association (EFTA) & the European Economic Area (EEA) and has harmonized its medical device regulations with the MDR.
Reasons to subscribe to Norway cell separation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway cell separation market databook
-
Our clientele includes a mix of cell separation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway cell separation market , including forecasts for subscribers. This country databook contains high-level insights into Norway cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway cell separation market size, by product, 2018-2030 (US$M)
Norway Cell Separation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
